Literature DB >> 30063965

Cysteine cathepsins: Their biological and molecular significance in cancer stem cells.

Anja Pišlar1, Anahid Jewett2, Janko Kos3.   

Abstract

Cysteine cathepsins are lysosomal peptidases involved on one hand in general intracellular protein degradation and, on the other, in the regulation of a number of specific physiological processes. Their integral role in extracellular matrix degradation and in processing growth factors, hormones and adhesion proteins is a driving force in cancer progression, triggering tumor proliferation, invasion, angiogenesis and metastasis. Cancer stem cells are proposed to be a main factor of tumor initialization, heterogeneity and resistance to therapy. Recent studies have uncovered increased expression, aberrant localization and disturbed functions of certain cysteine cathepsins in these cells, in particular in glioblastoma stem cells. Here, we review the research that have underlined the expression patterns and roles of cysteine cathepsins in cancer stem cells, and emphasize the involvement of cysteine cathepsins in caspase-independent cell death and in regulating interaction between cancer stem cells and immune cells such as natural killer cells.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Cancer stem cells; Cells of the immune system; Cystatin; Cysteine cathepsins

Mesh:

Substances:

Year:  2018        PMID: 30063965     DOI: 10.1016/j.semcancer.2018.07.010

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  14 in total

1.  CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.

Authors:  Zun Mao; Miao-Miao Sang; Cheng Chen; Wen-Tao Zhu; Yu-Sen Gong; Dong-Sheng Pei
Journal:  Int J Biol Sci       Date:  2019-05-12       Impact factor: 6.580

Review 2.  Biguanide is a modifiable pharmacophore for recruitment of endogenous Zn2+ to inhibit cysteinyl cathepsins: review and implications.

Authors:  Thomas D Lockwood
Journal:  Biometals       Date:  2019-05-01       Impact factor: 2.949

Review 3.  Cysteine Cathepsins in Tumor-Associated Immune Cells.

Authors:  Tanja Jakoš; Anja Pišlar; Anahid Jewett; Janko Kos
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

4.  Evaluation of serum cathepsin B, D, and L concentrations in women with late-onset preeclampsia.

Authors:  Gökçe Anık İlhan; Begüm Yıldızhan
Journal:  Turk J Obstet Gynecol       Date:  2019-07-03

5.  Cathepsin L promotes angiogenesis by regulating the CDP/Cux/VEGF-D pathway in human gastric cancer.

Authors:  Tao Pan; Zhijian Jin; Zhenjia Yu; Xiongyan Wu; Xinyu Chang; Zhiyuan Fan; Fangyuan Li; Xiaofeng Wang; Zhen Li; Quan Zhou; Jianfang Li; Bingya Liu; Liping Su
Journal:  Gastric Cancer       Date:  2020-05-09       Impact factor: 7.370

6.  The canine activated platelet secretome (CAPS): A translational model of thrombin-evoked platelet activation response.

Authors:  Signe E Cremer; James L Catalfamo; Robert Goggs; Stefan E Seemann; Annemarie T Kristensen; Paulina B Szklanna; Patricia B Maguire; Marjory B Brooks
Journal:  Res Pract Thromb Haemost       Date:  2020-12-03

Review 7.  A Key Pathway to Cancer Resilience: The Role of Autophagy in Glioblastomas.

Authors:  Elisa Helena Farias Jandrey; Marcelle Bezerra; Lilian Tiemi Inoue; Frank B Furnari; Anamaria Aranha Camargo; Érico Tosoni Costa
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

Review 8.  Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.

Authors:  Anamarija Habič; Metka Novak; Bernarda Majc; Tamara Lah Turnšek; Barbara Breznik
Journal:  J Histochem Cytochem       Date:  2021-07-26       Impact factor: 2.479

9.  Cystatin C and cystatin SN as possible soluble tumor markers in malignant uveal melanoma.

Authors:  Maria A Dikovskaya; Galina S Russkikh; Konstantin V Loktev; Thomas P Johnston; Margarita M Gevorgyan; Natalya P Voronina; Valery V Chernykh; Alexander N Trunov; Tatiana A Korolenko
Journal:  Radiol Oncol       Date:  2021-12-22       Impact factor: 2.991

10.  CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.

Authors:  Kaiming Ma; Xin Chen; Weihai Liu; Suhua Chen; Chenlong Yang; Jun Yang
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.